Hyloris Pharmaceuticals SA, has announced that its partner for Maxigesic IV, AFT Pharmaceuticals, has signed an exclusive license and distribution agreement with Hikma Pharmaceuticals for the U.S. commercialization of Maxigesic IV, a novel, patented ...